BDT Capital, a private equity firm, agreed to acquire a majority stake in MJH Life Sciences, a full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, for $2.5bn. “In order to continue to enhance overall engagement between healthcare professionals and pharma, we’ve sought a long-term capital partner to continue to grow our audience reach, and ensure we will continue to provide best-in-class service to our clients well into the future. We have purposefully and diligently selected a partner in BDT who honors our values and competitive spirit, while also demonstrating the ability to support our vision and add meaningful strategic value," Mike Hennessy, MJH Life Sciences CEO.